US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Market Highlights: Italy Depression – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, depression drugs market share, depression drugs sales estimates, depression drugs sales forecast, and depression late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Update: Narcolepsy Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 590
Market Highlights: Spain Depression – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, depression drugs market share, depression drugs sales estimates, depression drugs sales forecast, and depression late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Germany Depression – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, depression drugs market share, depression drugs sales estimates, depression drugs sales forecast, and depression late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Italy Glioblastoma – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, glioblastoma drugs market share, glioblastoma drugs sales estimates, glioblastoma drugs sales forecast, and glioblastoma late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Japan Glioblastoma – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, glioblastoma drugs market share, glioblastoma drugs sales estimates, glioblastoma drugs sales forecast, and glioblastoma late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Update: Depression Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 590
Update: Traumatic Brain Injury Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... It covers emerging therapies for Traumatic Brain Injury in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 590
Update: Glioma Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 590
Update: Migraine Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 590
Update: Brain Cancer Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Brain Cancer in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
Update: Autism Spectrum Disorder Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... It covers emerging therapies for Autism Spectrum Disorder in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating ...  |  read more...
USD 590
Update: Cocaine Dependence Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Cocaine Dependence in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
Update: Peripheral Neuropathy Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Peripheral Neuropathy in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
Market Highlights: US Depression – 2014
5/1/2014 | published by: Fore Pharma
... the US depression market size estimates for 2013, market share forecast for six years to 2019, depression drugs market share, depression drugs sales estimates, depression drugs sales forecast, and depression late stage pipeline products.This research ...  |  read more...
USD 990
Market Highlights: UK Migraine – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, and migraine late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: Germany Migraine – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, and migraine late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: France Migraine – 2014
5/1/2014 | published by: Fore Pharma
... market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, and migraine late stage pipeline products.This research helps executives track ...  |  read more...
USD 990
Market Highlights: US Migraine – 2014
5/1/2014 | published by: Fore Pharma
... the US migraine market size estimates for 2013, market share forecast for six years to 2019, migraine drugs market share, migraine drugs sales estimates, migraine drugs sales forecast, and migraine late stage pipeline products.This research ...  |  read more...
USD 990
Market Highlights: UK Bipolar Disorder – 2014
5/1/2014 | published by: Fore Pharma
... research includes UK bipolar disorder market size estimates for 2013, market share forecast for six years to 2019, bipolar disorder drugs market share, bipolar disorder drugs sales estimates, bipolar disorder drugs sales forecast, and bipolar ...  |  read more...
USD 990
Clinical Development and Trial Operations: Protocol Design and Cost Per Patient Benchmarks
11/1/2013 | published by: Cutting Edge Information
... in this benchmarking study. The report is designed to provide clinical development executives the decision making tools necessary to minimize these challenges and arrive at successful clinical endpoints. The data include key performance indicators, such ...  |  read more...
USD 6,495
OpportunityAnalyzer: Autism Spectrum Disorder - Opportunity Analysis and Forecasts to 2018
3/12/2014 | published by: GlobalData
... is off-label use of a multitude of other drugs which target different core and non-core symptoms of ASD. Since this disorder can first become apparent in very young children there is a need for medications ...  |  read more...
USD 7,995
PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023
3/31/2014 | published by: GlobalData
... during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes ...  |  read more...
USD 10,995
Neuroblastoma Global Clinical Trials Review, H1, 2014
3/27/2014 | published by: GlobalData
... relating to the clinical trials on Neuroblastoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Low-Grade Astrocytoma Global Clinical Trials Review, H1, 2014
3/31/2014 | published by: GlobalData
... information and data relating to the clinical trials on Low-Grade Astrocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
3  4  5  6    8    10  11  12